Literature DB >> 34232459

Patient ethnicity and cascade genetic testing: a descriptive study of a publicly funded hereditary cancer program.

Eryn F Braley1, Angela C Bedard2,3,4, Sophie Sun5,6, Kasmintan A Schrader5,7,8, Jennifer Nuk5,8, Quan Hong5, James E J Bedard1.   

Abstract

Cascade genetic testing for hereditary cancer is highly accurate and cost-effective for identifying individuals at high risk for cancer; however, not all eligible people utilize this service. While sociodemographic factors related to the uptake of cascade genetic testing, such as age and sex, have been fairly well described in the literature, there is limited data available regarding patient ethnicity. We analyzed four years of testing data for this factor, as well as sex, age and genes tested. The patients were seen by the Hereditary Cancer Program of BC Cancer, which serves the entire population of British Columbia and Yukon, Canada. Patient ethnicity was compared to the 2016 Census data from the same region. Fisher's exact test was conducted to explore the cascade genetic testing uptakes. Chi-square test was used to compare the major ethnicity groups to Census data. There was significant variability in the uptake of cascade genetic testing in the three largest population groups (p < 0.05), with individuals of European ethnic origin overrepresented, individuals of Asian ethnic origin modestly underrepresented, and individuals of North American Indigenous origin considerably underrepresented for cascade genetic testing. The proportions represented compared to those expected from census data were significantly different for these three largest groups (p < 0.01). The majority of cascade genetic tests were for BRCA1/BRCA2 (58.8%), followed by 16.9% for Lynch syndrome genes. Most patients were female (70%), and the mean age of patients was 49 years old. This study provides further insight into uptake of cascade genetic testing by patient ethnicity. Examining patient ethnicity and cascade genetic testing rates helps to identify underserved populations. Our analysis highlights significant underrepresentation of North American Indigenous individuals for hereditary cancer cascade genetic testing, and helps recognize the need for development of culturally-safe alternatives to outreach and service promotion.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Ethnicity; Genetic testing; Indigenous health; Predictive testing; Screening

Mesh:

Year:  2021        PMID: 34232459     DOI: 10.1007/s10689-021-00270-0

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.446


  10 in total

Review 1.  Racial/Ethnic Disparities in BRCA Counseling and Testing: a Narrative Review.

Authors:  Christina D Williams; Alyssa Jasmine Bullard; Meghan O'Leary; Reana Thomas; Thomas S Redding; Karen Goldstein
Journal:  J Racial Ethn Health Disparities       Date:  2019-04-08

2.  The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.

Authors:  Fred H Menko; Jacqueline A Ter Stege; Lizet E van der Kolk; Kiki N Jeanson; Winnie Schats; Daoud Ait Moha; Eveline M A Bleiker
Journal:  Fam Cancer       Date:  2019-01       Impact factor: 2.375

3.  Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.

Authors:  Deborah Cragun; Anne Weidner; Courtney Lewis; Devon Bonner; Jongphil Kim; Susan T Vadaparampil; Tuya Pal
Journal:  Cancer       Date:  2017-02-09       Impact factor: 6.860

4.  Partnering with Indigenous Elders in primary care improves mental health outcomes of inner-city Indigenous patients: Prospective cohort study.

Authors:  David Tu; George Hadjipavlou; Jennifer Dehoney; Elder Roberta Price; Caleb Dusdal; Annette J Browne; Colleen Varcoe
Journal:  Can Fam Physician       Date:  2019-04       Impact factor: 3.275

5.  Genetic testing in families with hereditary colorectal cancer in British Columbia and Yukon: a retrospective cross-sectional analysis.

Authors:  Vivienne K Beard; Angela C Bedard; Jennifer Nuk; Petra W C Lee; Quan Hong; James E J Bedard; Sophie Sun; Kasmintan A Schrader
Journal:  CMAJ Open       Date:  2020-10-19

6.  Cancer in First Nations people living in British Columbia, Canada: an analysis of incidence and survival from 1993 to 2010.

Authors:  Colleen E McGahan; Kevin Linn; Preston Guno; Harmony Johnson; Andrew J Coldman; John J Spinelli; Nadine R Caron
Journal:  Cancer Causes Control       Date:  2017-09-08       Impact factor: 2.506

Review 7.  Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.

Authors:  Ravi N Sharaf; Parvathi Myer; Christopher D Stave; Lisa C Diamond; Uri Ladabaum
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-10       Impact factor: 11.382

8.  Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center.

Authors:  Eloise Chapman-Davis; Zhen Ni Zhou; Jessica C Fields; Melissa K Frey; Bailey Jordan; Katherine J Sapra; Sudeshna Chatterjee-Paer; Ann D Carlson; Kevin M Holcomb
Journal:  J Gen Intern Med       Date:  2020-07-27       Impact factor: 5.128

Review 9.  Blending Aboriginal and Western healing methods to treat intergenerational trauma with substance use disorder in Aboriginal peoples who live in northeastern Ontario, Canada.

Authors:  Teresa Naseba Marsh; Diana Coholic; Sheila Cote-Meek; Lisa M Najavits
Journal:  Harm Reduct J       Date:  2015-05-20

10.  Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative.

Authors:  Jennifer L Caswell-Jin; Anjali D Zimmer; Will Stedden; Kerry E Kingham; Alicia Y Zhou; Allison W Kurian
Journal:  J Natl Cancer Inst       Date:  2019-01-01       Impact factor: 13.506

  10 in total
  4 in total

1.  Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada.

Authors:  Shamini Selvarajah; Kasmintan A Schrader; Michael P Kolinsky; Ricardo A Rendon; Soufiane El Hallani; Neil E Fleshner; Sebastien J Hotte; Justin Lorentz; Karen Panabaker; Renée Perrier; Frédéric Pouliot; Alan Spatz; Stephen Yip; Kim N Chi
Journal:  Can Urol Assoc J       Date:  2022-10       Impact factor: 2.052

2.  Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort.

Authors:  Mahesh Sarki; Chang Ming; Souria Aissaoui; Nicole Bürki; Maria Caiata-Zufferey; Tobias Ephraim Erlanger; Rossella Graffeo-Galbiati; Karl Heinimann; Viola Heinzelmann-Schwarz; Christian Monnerat; Nicole Probst-Hensch; Manuela Rabaglio; Ursina Zürrer-Härdi; Pierre Olivier Chappuis; Maria C Katapodi
Journal:  Cancers (Basel)       Date:  2022-03-23       Impact factor: 6.639

3.  The Impact of Proband Indication for Genetic Testing on the Uptake of Cascade Testing Among Relatives.

Authors:  Tara J Schmidlen; Sara L Bristow; Kathryn E Hatchell; Edward D Esplin; Robert L Nussbaum; Eden V Haverfield
Journal:  Front Genet       Date:  2022-06-16       Impact factor: 4.772

Review 4.  Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention.

Authors:  Lauren C Tindale; Almira Zhantuyakova; Stephanie Lam; Michelle Woo; Janice S Kwon; Gillian E Hanley; Bartha Knoppers; Kasmintan A Schrader; Stuart J Peacock; Aline Talhouk; Trevor Dummer; Kelly Metcalfe; Nora Pashayan; William D Foulkes; Ranjit Manchanda; David Huntsman; Gavin Stuart; Jacques Simard; Lesa Dawson
Journal:  Curr Oncol       Date:  2022-06-30       Impact factor: 3.109

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.